Cognitive Dysfunction in Depression: Lessons Learned from Animal Models

Author(s): Gislaine Z. Reus, Helena M. Abelaira, Daniela D. Leffa, Joao Quevedo.

Journal Name: CNS & Neurological Disorders - Drug Targets
(Formerly Current Drug Targets - CNS & Neurological Disorders)

Volume 13 , Issue 10 , 2014

Become EABM
Become Reviewer


Major depression is a serious public health problem and one of the most common psychiatric disorders, and it is estimated that millions of people are affected worldwide. In addition, patients having depression present cognitive impairments, which could influence treatment adherence and long-term outcomes. Although, studies have shown that alterations in the hypothalamic–pituitary–adrenal axis, in inflammatory and antioxidant systems, and changes in intracellular pathways are involved in the cognitive impairment verified in depressive patients, it was unclear how these alterations occur. In this context, animal models of psychiatric disorders are revealed as good alternatives for the study of pathophysiology of these and associated factors. Thus, this review will highlight studies with animal models that have helped in understanding the mechanisms involved in cognitive impairment associated with depression, as well as focus on effective treatments that assist in improving both depression and cognition.

Keywords: Animal models, cellular survival pathway, cognition, depression, immune system, neuroendocrine system.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [1860 - 1870]
Pages: 11
DOI: 10.2174/1871527313666141130223453
Price: $58

Article Metrics

PDF: 28